|Articles|November 10, 2022
- Applied Clinical Trials-11-01-2022
- Volume 31
- Issue 11
Applied Clinical Trials November 2022 Issue (PDF)
Advertisement
Articles in this issue
almost 4 years ago
Mobilizing and Maintaining Clinical Trials in Midst of Waralmost 4 years ago
The Implications of Inflation for Drug Developmentalmost 4 years ago
Implementing Numeric Rating and Visual Analog Scales in an eCOA Solutionalmost 4 years ago
‘Dogma’ About Innovation vs. Access Impeding EU Fixes for Rare Diseasesalmost 4 years ago
When Does Patient Centricity Equal Burden?almost 4 years ago
The State of Data FAIRification in Clinical Researchalmost 4 years ago
“Culture of Quality” In Actionalmost 4 years ago
FDA Expands Oversight of Cell and Gene Therapiesalmost 4 years ago
Anticipating Careless Responders in Survey Design and Analysisabout 4 years ago
Towards a Global Implementation of eConsent in Clinical TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Workforce Compression in AI-Driven Clinical Trial Operations
2
Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First
3
ACT Brief: Site Cash Runway and Payment Infrastructure Priority, Biomarker Cut-Off Selection and Disparities, and Batch Failure Prevention Systems
4
Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology
5